Testosterone undecanoate
Showing 1 - 25 of 932
Hypoactive Sexual Desire Disorder Trial in San Diego (Oral Testosterone Undecanoate)
Not yet recruiting
- Hypoactive Sexual Desire Disorder
- Oral Testosterone Undecanoate
-
San Diego, CaliforniaSan Diego Sexual Medicine
Oct 12, 2023
Boys With Pubertal Delay or Confirmed Hypogonadism
Recruiting
- Delayed Puberty
- Male Hypogonadism
- Testosterone Undecanoate
-
Buenos Aires, Distrito Federal, ArgentinaRodolfo Rey
Sep 12, 2022
Healthy Aging, Age-Related Sarcopenia, Testosterone Deficiency Trial (Saline, Testosterone Undecanoate)
Not yet recruiting
- Healthy Aging
- +2 more
- Saline
- Testosterone Undecanoate
- (no location specified)
Jul 19, 2023
Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Baltimore
Recruiting
- Prostate Cancer
- +2 more
- Testosterone Undecanoate
- Enzalutamide
-
Baltimore, MarylandJohns Hopkins Hospital
May 6, 2022
Bariatric Surgery Candidate, Male Hypogonadism, Muscle Loss Trial in Esbjerg (Testosterone Undecanoate)
Recruiting
- Bariatric Surgery Candidate
- +2 more
- Testosterone Undecanoate
-
Esbjerg, DenmarkHospitalSWD
Oct 24, 2022
Opioid Use, Pain, Hypogonadism, Male Trial in Boston (Testosterone Undecanoate 250 MG/ML, Placebo)
Recruiting
- Opioid Use
- +2 more
- Testosterone Undecanoate 250 MG/ML
- Placebo
-
Boston, MassachusettsBrigham and Women's Hospital
Sep 16, 2022
Gender Dysphoria, Gender Identity, Gender Issues Trial (Testosterone treatment, Placebo treatment)
Not yet recruiting
- Gender Dysphoria
- +2 more
- Testosterone treatment
- Placebo treatment
- (no location specified)
Dec 11, 2022
Hypogonadism, Male, Fatigue Syndrome, Chronic Trial in Boston, Seattle (Testosterone Undecanoate 750 MG/3 ML Intramuscular
Recruiting
- Hypogonadism, Male
- Fatigue Syndrome, Chronic
- Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED]
- placebo
-
Boston, Massachusetts
- +1 more
Aug 11, 2022
Contraception Trial (etonogestrel with testosterone undecanoate, Placebo)
Completed
- Contraception
- etonogestrel with testosterone undecanoate
- Placebo
- (no location specified)
Feb 2, 2022
Hypogonadism Trial in Birmingham, Los Angeles, San Antonio (Oral testosterone undecanoate (TU) (300 mg T equivalents/dose), Oral
Completed
- Hypogonadism
- Oral testosterone undecanoate (TU) (300 mg T equivalents/dose)
- +3 more
-
Birmingham, Alabama
- +3 more
Jun 23, 2021
Spinal Cord Injuries Trial in Boston (Testosterone Undecanoate, hybrid exercise)
Recruiting
- Spinal Cord Injuries
- Testosterone Undecanoate
- hybrid exercise
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 11, 2022
Multiple Sclerosis, Relapsing-Remitting Trial in France (drug, procedure, behavioral)
Recruiting
- Multiple Sclerosis, Relapsing-Remitting
- Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection
- +4 more
-
Besançon, France
- +3 more
Oct 18, 2021
Male Hypogonadism Trial in Torrance, Quebec City (Oral testosterone undecanoate (containing 300 mg T))
Completed
- Male Hypogonadism
- Oral testosterone undecanoate (containing 300 mg T)
-
Torrance, California
- +1 more
Nov 6, 2020
Male Hypogonadism, Primary Hypogonadism, Secondary Hypogonadism Trial in Birmingham (Testosterone undecanoate)
Completed
- Male Hypogonadism
- +2 more
- Testosterone undecanoate
-
Birmingham, AlabamaAlabama Clinical Therapeutics
Dec 10, 2020
Male Hypogonadism Trial in Germany, United States (Oral testosterone undecanoate, Transdermal testosterone gel (AndroGel))
Completed
- Male Hypogonadism
- Oral testosterone undecanoate
- Transdermal testosterone gel (AndroGel)
-
Birmingham, Alabama
- +29 more
Jun 25, 2021
Transgenderism, Hypogonadism Trial (dutasteride 5 mg/day, Testosterone Undecanoate)
Completed
- Transgenderism
- Hypogonadism
- dutasteride 5 mg/day
- Testosterone Undecanoate
- (no location specified)
Sep 3, 2020
Male Hypogonadism Trial in Sheffield (DITEST, Testosterone undecanoate)
Completed
- Male Hypogonadism
- DITEST
- Testosterone undecanoate
-
Sheffield, England, United KingdomSheffield Teaching Hospital - Royal Hallamshire Hospital
Nov 25, 2019
Arthroplasty, Replacement, Hip Trial in Des Plaines (Testosterone Therapy, No Testosterone Therapy)
Withdrawn
- Arthroplasty, Replacement, Hip
- Testosterone Therapy
- No Testosterone Therapy
-
Des Plaines, IllinoisAmerican Hip Institute Research Foundation
Feb 1, 2023
Prostate Cancer Recurrent Trial in Malmö (Degarelix 120 MG [Firmagon], Gonal F RFF Pen 900 UNT Per 1.5 ML Pen Injector,
Completed
- Prostate Cancer Recurrent
- Degarelix 120 MG [Firmagon]
- +2 more
-
Malmö, SwedenReproductive Medicine Center
Jan 21, 2020